Sort
141,003 grants matching “cytokine”
Quantitative control of CAR T cells via image-guided delivery and monitoring
$638,831Daniel J. Powell · University Of Pennsylvania · R01 · FY2021 · EB
CEBPD-Mediated Mechanisms of Glucocorticoid Insensitivity in Severe Asthma
$638,831Blanca E Himes · University Of Pennsylvania · R01 · FY2019 · HL
Autonomic, Endothelial, and Inflammatory Correlates of Sleep Duration
$638,820Mercedes Renee Carnethon · Northwestern University At Chicago · R01 · FY2010 · HL
Bioprinting 3D skin for patient-specific drug discovery in inflammatory skin diseases.
$638,800Angela M Christiano · Columbia University Health Sciences · U18 · FY2018 · TR
Core B -- BioCore
$638,794Christopher L. Coe · University Of Wisconsin-Madison · U19 · FY2022 · AG
Immune Mechanisms Regulating Allergy
$638,744Stephanie Caroline Eisenbarth · Northwestern University At Chicago · R01 · FY2024 · AI
Neurobehavioral Correlates of Mental Stress Ischemia
$638,669Robert Soufer · Yale University · R01 · FY2009 · HL
Specific T and B cell responses to candidate Treponema pallidum outer membrane protein vaccine antigens
$638,650David M Koelle · University Of Washington · U19 · FY2023 · AI
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease
$638,645Jason V Baker · Hennepin Healthcare Research Institute · R01 · FY2014 · HL
Hopkins Lupus Cohort
$638,643Michelle A Petri · Johns Hopkins University · R01 · FY2010 · AR
The IL-33/ILC2 axis in parturition
$638,635Adrian Erlebacher · University Of California, San Francisco · R01 · FY2020 · AI
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
$638,624Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2020 · ES
Development of Antibody and T-Cell Inducing Vaccines
$638,623Philip O. Livingston · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$638,608Donald Ym Leung · National Jewish Health · U01 · FY2020 · AR
Pathogenesis of Clade C HIV Infection
$638,597Bruce D Walker · Massachusetts General Hospital · R37 · FY2011 · AI
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV
$638,580Carla J Chibwesha · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Longitudinal Neurometabolic Outcomes of Traumatic Stress-Related Accelerated Cellular Aging
$638,570Erika J Wolf · Boston University Medical Campus · R01 · FY2024 · AG
Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation
$638,560Ali G Gharavi · Columbia University Health Sciences · R01 · FY2024 · DK
Thromboregulatory strategies to prolong xenograft survival.
$638,482Simon C Robson · Beth Israel Deaconess Medical Center · U01 · FY2007 · AI
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
$638,461James Walter Kazura · Case Western Reserve University · R01 · FY2011 · AI
Evaluating the role of P53 pathways in malaria
$638,439Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2021 · AI
Regulation of hematopoietic regeneration in the aging marrow by bone
$638,393Stavroula Kousteni · Columbia University Health Sciences · P01 · FY2025 · AG
Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system
$638,381Christina Gavegnano · Emory University · R01 · FY2023 · MH
Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system
$638,381Albert Anderson · Emory University · R01 · FY2022 · MH
Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system
$638,381Christina Gavegnano · Emory University · R01 · FY2025 · MH